Apellis Pharmaceuticals general counsel sells $20,518 in stock
David O. Watson, the General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold a portion of his holdings ...
Apellis Pharmaceuticals chief scientific officer sells $24,386 in stock
Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold 826 shares of the company's common stock. The shares were sold at an average price of ...